This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide pharmaceutical and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract, valued at $4,488.28, is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, worth up to $999,999,999.00 and running through November 2026.
This contract covers a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas such as cardiovascular health, diabetes management, mental health, pain management, infectious disease prevention, and general medical care. The contract was awarded on a full and open competition basis without any set-aside designations, reflecting Amerisourcebergen's strong position in the pharmaceutical distribution market. In addition to the DLA contract, Cencora, Inc. also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Generated 2/27/25, 12:08 PM